The Limitations of Endogenous GLP-1 and GIP Production for Obesity Treatment

This chapter discusses the limitations of increasing the body's own production of GLP-1 and GIP to treat obesity. It highlights the ineffectiveness of traditional methods like nutrition and exercise and provides an overview of the history of anti-obesity drugs. The chapter emphasizes the importance of weight loss for health improvement and introduces the new drug, Zepitide, which has shown significant weight loss results.